1. Home
  2. GBTG vs LQDA Comparison

GBTG vs LQDA Comparison

Compare GBTG & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Business Travel Group Inc.

GBTG

Global Business Travel Group Inc.

HOLD

Current Price

$5.56

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$37.64

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBTG
LQDA
Founded
2014
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
GBTG
LQDA
Price
$5.56
$37.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$9.40
$41.00
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
173.33
51.81
EPS
0.22
N/A
Revenue
$2,718,000,000.00
$158,320,000.00
Revenue This Year
$22.44
$265.61
Revenue Next Year
$4.36
$62.82
P/E Ratio
$25.36
N/A
Revenue Growth
12.17
1031.18
52 Week Low
$4.96
$11.26
52 Week High
$8.64
$46.67

Technical Indicators

Market Signals
Indicator
GBTG
LQDA
Relative Strength Index (RSI) 49.41 55.12
Support Level $5.29 $31.75
Resistance Level $5.86 $39.19
Average True Range (ATR) 0.19 1.80
MACD 0.04 0.20
Stochastic Oscillator 59.20 77.42

Price Performance

Historical Comparison
GBTG
LQDA

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: